What is MassTech?
MassTech Inc. is a key player in the scientific and pharmaceutical industries, focusing on the development and application of AP-MALDI mass spectrometry technology. Their product portfolio includes the MT Explorer 30 and various AP/MALDI ion sources, designed to enhance mass spectrometry capabilities. The company serves clients involved in mass spectrometry and drug discovery, offering innovative solutions and expert consultations. MassTech's commitment to advancing technology is evident in their user-friendly designs and active participation in industry events, showcasing their expertise and product offerings.
How much funding has MassTech raised?
MassTech has raised a total of $309K across 2 funding rounds:
Debt
$150K
Debt
$159K
Debt (2020): $150K with participation from PPP
Debt (2021): $159K led by PPP
Key Investors in MassTech
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for MassTech?
The substantial late-stage funding MassTech has received signals a strategic pivot towards scaling operations and potentially expanding its market reach. This capital infusion is likely to fuel further research and development into next-generation AP-MALDI mass spectrometry technologies, as well as bolster manufacturing and distribution capabilities. The company's focus on scientific and pharmaceutical sectors suggests potential for strategic partnerships or acquisitions to accelerate innovation and market penetration. MassTech appears poised to solidify its position as a leader in advanced mass spectrometry solutions.
See full MassTech company page
